These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 1981724)

  • 1. Biotransformation of sufentanil in liver microsomes of rats, dogs, and humans.
    Lavrijsen K; Van Houdt J; Van Dyck D; Hendrickx J; Lauwers W; Hurkmans R; Bockx M; Janssen C; Meuldermans W; Heykants J
    Drug Metab Dispos; 1990; 18(5):704-10. PubMed ID: 1981724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Excretion and biotransformation of alfentanil and sufentanil in rats and dogs.
    Meuldermans W; Hendrickx J; Lauwers W; Hurkmans R; Swysen E; Thijssen J; Timmerman P; Woestenborghs R; Heykants J
    Drug Metab Dispos; 1987; 15(6):905-13. PubMed ID: 2893720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism of alfentanil by isolated hepatocytes of rat and dog.
    Lavrijsen K; Van Houdt J; Meuldermans W; Knaeps F; Hendrickx J; Lauwers W; Hurkmans R; Heykants J
    Xenobiotica; 1988 Feb; 18(2):183-97. PubMed ID: 3131971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biotransformation of 6-methoxy-3-(3',4',5'-trimethoxy-benzoyl)-1H-indole (BPR0L075), a novel antimicrotubule agent, by mouse, rat, dog, and human liver microsomes.
    Yao HT; Wu YS; Chang YW; Hsieh HP; Chen WC; Lan SJ; Chen CT; Chao YS; Chang L; Sun HY; Yeh TK
    Drug Metab Dispos; 2007 Jul; 35(7):1042-9. PubMed ID: 17403915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative metabolism of flunarizine in rats, dogs and man: an in vitro study with subcellular liver fractions and isolated hepatocytes.
    Lavrijsen K; van Houdt J; van Dyck D; Hendrickx J; Bockx M; Hurkmans R; Meuldermans W; Le Jeune L; Lauwers W; Heykants J
    Xenobiotica; 1992 Jul; 22(7):815-36. PubMed ID: 1455902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biotransformation of tolterodine, a new muscarinic receptor antagonist, in mice, rats, and dogs.
    Andersson SH; Lindgren A; Postlind H
    Drug Metab Dispos; 1998 Jun; 26(6):528-35. PubMed ID: 9616187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro metabolism of a new anticancer agent, 6-N-formylamino-12, 13-dihydro-1,11-dihydroxy-13-(beta-D-glucopyranosil)5H-indolo+ ++[2,3-a]pyrrolo[3,4-c]carbazole-5,7(6H)-dione (NB-506), in mice, rats, dogs, and humans.
    Takenaga N; Hasegawa T; Ishii M; Ishizaki H; Hata S; Kamei T
    Drug Metab Dispos; 1999 Feb; 27(2):213-20. PubMed ID: 9929505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biotransformation of lovastatin. II. In vitro metabolism by rat and mouse liver microsomes and involvement of cytochrome P-450 in dehydrogenation of lovastatin.
    Vyas KP; Kari PH; Prakash SR; Duggan DE
    Drug Metab Dispos; 1990; 18(2):218-22. PubMed ID: 1971576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
    Beland FA
    Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biotransformation of felodipine in liver microsomes from rat, dog, and man.
    Bäärnhielm C; Backman A; Hoffmann KJ; Weidolf L
    Drug Metab Dispos; 1986; 14(5):613-8. PubMed ID: 2876870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism of a nitrogen-containing steroid by rat hepatocytes and hepatic subcellular fractions.
    Kedderis GL; Argenbright LS; Walsh JS; Smith JL; Stearns RA; Arison BA; Miwa GT
    Drug Metab Dispos; 1989; 17(6):606-11. PubMed ID: 2575495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biotransformation of the anti-angiogenic compound SU5416.
    Antonian L; Zhang H; Yang C; Wagner G; Shawver LK; Shet M; Ogilvie B; Madan A; Parkinson A
    Drug Metab Dispos; 2000 Dec; 28(12):1505-12. PubMed ID: 11095590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolism of prazosin in rat, dog, and human liver microsomes and cryopreserved rat and human hepatocytes and characterization of metabolites by liquid chromatography/tandem mass spectrometry.
    Erve JC; Vashishtha SC; DeMaio W; Talaat RE
    Drug Metab Dispos; 2007 Jun; 35(6):908-16. PubMed ID: 17353349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro metabolism of nefiracetam by liver microsomes from rats, dogs and monkeys.
    Fujimaki Y; Sudo K; Hakusui H
    Arzneimittelforschung; 1995 Jul; 45(7):748-52. PubMed ID: 8573215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in cytochrome P450-mediated biotransformation of 1,2-dichlorobenzene by rat and man: implications for human risk assessment.
    Hissink AM; Oudshoorn MJ; Van Ommen B; Haenen GR; Van Bladeren PJ
    Chem Res Toxicol; 1996 Dec; 9(8):1249-56. PubMed ID: 8951226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of cytochrome P450 2E1 in the species-dependent biotransformation of 1,2-dichloro-1,1,2-trifluoroethane in rats and mice.
    Dekant W; Assmann M; Urban G
    Toxicol Appl Pharmacol; 1995 Dec; 135(2):200-7. PubMed ID: 8545828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [In vitro comparison of thienorphine metabolism in liver microsomes of human, Beagle dog and rat].
    Deng JT; Zhuang XM; Li H
    Yao Xue Xue Bao; 2010 Jan; 45(1):98-103. PubMed ID: 21351457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro metabolism study of combretastatin A-4 in rat and human liver microsomes.
    Aprile S; Del Grosso E; Tron GC; Grosa G
    Drug Metab Dispos; 2007 Dec; 35(12):2252-61. PubMed ID: 17890446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on the metabolism of the novel, selective cyclooxygenase-2 inhibitor indomethacin phenethylamide in rat, mouse, and human liver microsomes: identification of active metabolites.
    Remmel RP; Crews BC; Kozak KR; Kalgutkar AS; Marnett LJ
    Drug Metab Dispos; 2004 Jan; 32(1):113-22. PubMed ID: 14709628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical pharmacokinetics and metabolism of 6-(4-(2,5-difluorophenyl)oxazol-5-yl)-3-isopropyl-[1,2,4]-triazolo[4,3-a]pyridine, a novel and selective p38alpha inhibitor: identification of an active metabolite in preclinical species and human liver microsomes.
    Kalgutkar AS; Hatch HL; Kosea F; Nguyen HT; Choo EF; McClure KF; Taylor TJ; Henne KR; Kuperman AV; Dombroski MA; Letavic MA
    Biopharm Drug Dispos; 2006 Nov; 27(8):371-86. PubMed ID: 16944451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.